Wong Alexandra K, Walkey Allan J
1 Department of Internal Medicine, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts; and.
2 Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, The Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts.
Ann Am Thorac Soc. 2015 Aug;12(8):1226-30. doi: 10.1513/AnnalsATS.201502-077BC.
Open lung biopsy may be performed to guide therapy in mechanically ventilated patients with diagnostic uncertainty regarding etiology of pulmonary infiltrates. Current evidence for open lung biopsy in mechanically ventilated patients comes from single-center case series.
We performed a metaanalysis of case series to determine diagnoses, complications, and changes in therapy after lung biopsy in critically ill patients requiring mechanical ventilation.
We searched Medline for case series of lung biopsies in critically ill patients requiring mechanical ventilation. We pooled results of individual case series using random effects metaanalysis models to obtain summary proportions.
We identified 14 case series including a total of 512 mechanically ventilated patients with 530 histopathological diagnoses. The most common diagnoses were "fibrosis/pneumonitis" (n = 155, 25%; 95% confidence interval [CI], 14-37%) and infection (n = 113, 20%; 95% CI, 15-27%). Viruses were the most commonly identified infectious etiology identified on open lung biopsy, representing 50% of potential pathogens. Diffuse alveolar damage was present in a minority of specimens (n = 100, 16%; 95% CI, 8-25%). Therapeutic changes after lung biopsy occurred in 399 patients (78%; 95% CI, 64-81%). Procedure-related complications occurred in 29% of patients (95% CI, 25-33%), most commonly persistent air leak. Mortality among mechanically ventilated patients after diagnostic open lung biopsy was 54%.
Among mechanically ventilated patients with respiratory failure of unclear etiology, lung biopsy yielded a wide range of diagnoses and was associated with a change in therapy in most patients.
对于机械通气患者,若肺部浸润病因诊断不明确,可进行开胸肺活检以指导治疗。目前关于机械通气患者开胸肺活检的证据来自单中心病例系列研究。
我们对病例系列进行了荟萃分析,以确定需要机械通气的重症患者肺活检后的诊断、并发症及治疗变化。
我们在Medline上搜索了需要机械通气的重症患者肺活检的病例系列。我们使用随机效应荟萃分析模型汇总各个病例系列的结果,以获得汇总比例。
我们确定了14个病例系列,共纳入512例机械通气患者,有530个组织病理学诊断。最常见的诊断为“纤维化/肺炎”(n = 155,25%;95%置信区间[CI],14 - 37%)和感染(n = 113,20%;95% CI,15 - 27%)。病毒是开胸肺活检中最常见的感染病因,占潜在病原体的50%。少数标本中存在弥漫性肺泡损伤(n = 100,16%;95% CI,8 - 25%)。399例患者(78%;95% CI,64 - 81%)在肺活检后治疗发生了变化。29%的患者出现了与操作相关的并发症(95% CI,25 - 33%),最常见的是持续性漏气。诊断性开胸肺活检后机械通气患者的死亡率为54%。
在病因不明的呼吸衰竭机械通气患者中,肺活检得出了广泛的诊断结果,且大多数患者的治疗发生了变化。